Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorArtromedical Konrad Malinowski Clinic

About this trial

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Eligibility criteria

Qualifiers

patients with ACL degeneratio mucosa decided to undergo a surgical treatment

range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI

Disqualifiers

non-adherence to the study protocol

active knee inflammation

range of motion impairment due to other extra- and intra-articular reasons

Trial design

Treatments tested in this trial

  • ACL "decompression"

Treatment groups

10 Participants
are divided into 1 treatment group